Skip to content

Archyworldys

  • Home
  • News
  • World
  • Business
  • Entertainment
  • Health
  • Sports
  • Technology

East Coast

East Coast Nor’easter Brings Heavy Rain, First Significant Snow

12/11/2026 by Natalie Ortiz — News & World Editor
East Coast Nor'easter Brings Heavy Rain, First Significant Snow

A developing nor’easter is tracking along the East Coast, bringing heavy rain, gusty winds, and the season’s first significant snowfall to millions of residents from Thursday, November 12, through Saturday, November 14, 2026.

Categories News Tags East Coast, New York

Search

Sections

  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Technology
  • World

Search:

Latest

  • Israeli Strike Kills Six in Gaza Hospital, Health Authority Says44 minutes ago
  • East Coast Nor’easter Brings Heavy Rain, First Significant Snow2 hours ago
  • U2 Releases Carnaval de Luz to Mark 50 Years of Music3 hours ago
  • Kemp Pushes to Save Harding’s Pits East Side From 50 Homes4 hours ago
  • Paris La Défense Plans to Convert Up to a Fifth of Offices into Apartments7 hours ago
  • Fewer Than One in 20 Council Artworks on Display, BBC Finds9 hours ago

Popular

  • PAGASA Alert: LPA Becomes Tropical Depression; Heavy Rain Forecast for Batanes and Babuyan Islands2 months ago
  • Israeli Strike Kills Six in Gaza Hospital, Health Authority Says20 minutes ago
  • Alex Gibney Debuts Nearly Four-Hour Elon Musk Documentary at TIFF2 months ago
  • Save $50: Best Soundcore AeroFit 2 Open Earbuds Deal by Anker2 months ago
  • Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications.2 months ago
  • Restaurant Rebuilds After Reality TV Makeover Missed the Mark2 months ago
  • Privacy Policy
  • About Us
  • Terms and Conditions
  • Accessibility Statement
  • Community Guidelines
  • Contact Us
  • Cookie Policy
  • Copyright Notice
  • Disclaimer
  • Do Not Sell / Share My Personal Information
  • Editorial Standards & Ethics
  • HTML Sitemap & RSS Feeds
  • Privacy Notice for California Residents

© 2026 Archyworldys. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]
© 2026 Archyworldys • Built with GeneratePress